Fresno County confirmed the first pediatric influenza and respiratory syncytial virus (RSV) death on Tuesday. By the numbers: ...

Fresno County health officials have confirmed the first pediatric deaths linked to flu and RSV this season, urging ...

Vermont has the second lowest state fatality rate in the US (146.4 per 100K; Hawaii 112.8/100K). Mississippi (463.1/100K) and Oklahoma (459.1/100K) have the highest rates. The US average is 306.7/100K ...

A new study published in the Journal of American Medical Association showed that nirsevimab offers protection against a ...

Nirsevimab-resistant respiratory syncytial virus variants remain rare, but continued molecular surveillance is crucial. Read ...

The incident occurred months after health authorities discovered the GP’s clinic had incorrectly stored vaccines, potentially ...

RSV leads to approximately 1.4 million hospitalizations and over 13,000 in-hospital deaths worldwide among infants under six ...

The NSW Government will offer nirsevimab, a type of monoclonal antibody immunisation to: Infants at birth not protected by maternal RSV vaccination; Infants at birth with certain medical conditions ...

Upcoming market catalysts for the second quarter of 2025 include the US approval decisions for clesrovimab (MK-1654) for respiratory syncytial virus (RSV) prophylaxis, sebetralstat for hereditary ...

Sanofi and AstraZeneca are closing in on EU approval of nirsevimab, their long-acting antibody for the protection of newborns and infants from respiratory syncytial virus (RSV) infections.

From next Monday, 17 March, free immunisation from respiratory syncytial virus (RSV) will be available to all newborn babies.It will mean all newborn ...